The world observes Diabetes Day on November 14. A Mumbai expert dissects the disease better to help people suffering from it and those taking care of them understand it better
Updated Dec 30, 2020 | 10:37 IST
The current study, published in the journal The American Association of Clinical Endocrinologists Clinical Case Reports, cautioned that COVID-19 patients receiving SGLT2i drugs may be at risk. Common diabetes drug may trigger rare complications for COVID-19 patients, say scientists | Photo Credits: Pixabay
Boston: Diabetes patients on a particular class of glucose-lowering drugs called SGLT2i may be at an increased risk for a potentially lethal condition when they contract COVID-19, warns a new study.
According to researchers from Brigham and Women s Hospital in the US, the condition known as diabetic ketoacidosis (DKA), can arise when illness prevents cells from receiving enough glucose to fuel their functioning.